LWCFA
PRAH

Loring Wolcott & Coolidge Fiduciary Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61
Closed -$6K – 752
2019
Q2 		$6K Buy
+61
New +$5.82K ﹤0.01% 599

Other funds holding PRAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's PRAH Position: Q3 2019 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 61 shares — an estimated $6K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in PRAH in Q2 2019 and held it in 1 quarter. The position peaked at $6K in Q2 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 61 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $6K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's PRA Health Sciences, Inc. position peaked at $6K in Q2 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.